These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
768 related items for PubMed ID: 17005691
1. EBNA-3B- and EBNA-3C-regulated cellular genes in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Chen A, Zhao B, Kieff E, Aster JC, Wang F. J Virol; 2006 Oct; 80(20):10139-50. PubMed ID: 17005691 [Abstract] [Full Text] [Related]
2. Structural, functional, and genetic comparisons of Epstein-Barr virus nuclear antigen 3A, 3B, and 3C homologues encoded by the rhesus lymphocryptovirus. Jiang H, Cho YG, Wang F. J Virol; 2000 Jul; 74(13):5921-32. PubMed ID: 10846073 [Abstract] [Full Text] [Related]
4. Determining the role of the Epstein-Barr virus Cp EBNA2-dependent enhancer during the establishment of latency by using mutant and wild-type viruses recovered from cottontop marmoset lymphoblastoid cell lines. Yoo L, Speck SH. J Virol; 2000 Dec; 74(23):11115-20. PubMed ID: 11070007 [Abstract] [Full Text] [Related]
6. RNA Sequencing Analyses of Gene Expression during Epstein-Barr Virus Infection of Primary B Lymphocytes. Wang C, Li D, Zhang L, Jiang S, Liang J, Narita Y, Hou I, Zhong Q, Zheng Z, Xiao H, Gewurz BE, Teng M, Zhao B. J Virol; 2019 Jul 01; 93(13):. PubMed ID: 31019051 [Abstract] [Full Text] [Related]
7. Transcriptional regulatory properties of Epstein-Barr virus nuclear antigen 3C are conserved in simian lymphocryptoviruses. Zhao B, Dalbiès-Tran R, Jiang H, Ruf IK, Sample JT, Wang F, Sample CE. J Virol; 2003 May 01; 77(10):5639-48. PubMed ID: 12719556 [Abstract] [Full Text] [Related]
9. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation. Harada S, Yalamanchili R, Kieff E. J Virol; 1998 Dec 01; 72(12):9948-54. PubMed ID: 9811732 [Abstract] [Full Text] [Related]
10. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. Ernberg I, Falk K, Minarovits J, Busson P, Tursz T, Masucci MG, Klein G. J Gen Virol; 1989 Nov 01; 70 ( Pt 11)():2989-3002. PubMed ID: 2479717 [Abstract] [Full Text] [Related]
11. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site. Zhao B, Sample CE. J Virol; 2000 Jun 01; 74(11):5151-60. PubMed ID: 10799590 [Abstract] [Full Text] [Related]
12. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells. Wolf J, Pawlita M, Klevenz B, Frech B, Freese UK, Müller-Lantzsch N, Diehl V, zur Hausen H. Int J Cancer; 1993 Feb 20; 53(4):621-7. PubMed ID: 8382194 [Abstract] [Full Text] [Related]
15. Biochemical characterization of Epstein-Barr virus nuclear antigen 3A and 3C proteins. Sample C, Parker B. Virology; 1994 Dec 20; 205(2):534-9. PubMed ID: 7975254 [Abstract] [Full Text] [Related]
16. Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro. Chen A, Divisconte M, Jiang X, Quink C, Wang F. J Virol; 2005 Apr 20; 79(7):4506-9. PubMed ID: 15767450 [Abstract] [Full Text] [Related]
17. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines. Kriauciunas KM, Goldstein BJ, Lipes MA, Kahn CR. J Cell Physiol; 1993 Mar 20; 154(3):486-95. PubMed ID: 8382208 [Abstract] [Full Text] [Related]
18. Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide. Farrell CJ, Lee JM, Shin EC, Cebrat M, Cole PA, Hayward SD. Proc Natl Acad Sci U S A; 2004 Mar 30; 101(13):4625-30. PubMed ID: 15070768 [Abstract] [Full Text] [Related]
20. Changes in the dominant Epstein-Barr virus type during human immunodeficiency virus infection. Buisson M, Morand P, Genoulaz O, Bourgeat MJ, Micoud M, Seigneurin JM. J Gen Virol; 1994 Feb 30; 75 ( Pt 2)():431-7. PubMed ID: 8113767 [Abstract] [Full Text] [Related] Page: [Next] [New Search]